DermTech Announces Favorable Coverage Policy With Blues Plan in Michigan for the Foundational Assay of Its DermTech Melanoma Test (DMT)Business Wire • 07/19/23
DermTech Adds Approximately 7 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)Business Wire • 07/12/23
DermTech Announces Restructuring to Prioritize Growth Opportunities and Streamline OperationsBusiness Wire • 06/28/23
ECRI Completes Evaluation of the Pigmented Lesion Assay (PLA), the Foundational Assay for the DermTech Melanoma Test (DMT)Business Wire • 06/14/23
DermTech Announces Contract With Hawaii Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT)Business Wire • 06/07/23
DermTech Surpasses 200,000 Cumulative Billable Samples for the DermTech Melanoma Test (DMT)Business Wire • 05/31/23
DermTech Announces Agreements With South Carolina Blues Plan and the United Mine Workers of America Health and Retirement Funds for the Foundational Assay of Its DermTech Melanoma Test (DMT)Business Wire • 05/11/23
DermTech Grants New CEO Bret Christensen Inducement Award Under NASDAQ Listing Rule 5635(c)(4)Business Wire • 05/10/23
New Survey Data Reveals Nearly 75% of Consumers Have Not Had a Full Skin Exam Within the Past 12 MonthsBusiness Wire • 05/01/23
DermTech Announces Contract With New York Health Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT)Business Wire • 04/26/23
DermTech Announces Contract With North Carolina Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT)Business Wire • 04/11/23
New Survey Finds Millennials and Gen Xers Not Following Safe Sun Habits, Increasing Risk of Nonmelanoma Skin CancerBusiness Wire • 04/05/23
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating DermTech, Inc. for Potential Breaches of Fiduciary Duty By Its Board of DirectorsPRNewsWire • 04/03/23
DermTech to Present Four New Posters and Demonstrate its Smart Stickers™ at the 2023 American Academy of Dermatology (AAD) Annual MeetingBusiness Wire • 03/14/23
DermTech Adds Approximately 1.9 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)Business Wire • 03/07/23